Medi'Care - Company Profile
Beijing Medi'Care Co., Ltd. was established in 2007 with headquarters in Beijing Airport Industrial Development Zone. As a GSP-certified pharmaceutical marketing foreign-funded enterprise, we are committed to the digital development of child health care with innovative integration of medical and pharmaceutical resources, empowerment of doctors and mother-to-child interactions.
We're a pioneer in launching the PDA circulation management system globally. We introduced RFID technology to the production, logistics and distribution system in 2009, and pioneered the global integrated solution of Item Level Tracking. By doing this, we become a leading player in the u-SCM technology for the links and extensions between different industries.
We have established close strategic cooperation with Hanmi Pharmaceutical Co., Ltd. and Beijing Hanmi Pharmaceutical Co., Ltd., and we are an important member of the marketing business of Hanmi Pharmaceutical Group. With a strong economic strength, unique market operation ability and long-term market planning, we've developed an independent marketing network, built good business reputation and accumulated rich experience in the grassroots medical care and prescription drug market. Besides the developed logistics system, we employ a unique open policy model to quickly gain a strong foothold in the market and achieve fast sales growth with new products . We stay committed to people-oriented management and aim to build our team with high efficiency, sharing, fraternity and enthusiasm. We remain committed to safeguarding health with high product quality in everything we do, constantly thinking to devote to the health development of Chinese children.
HanmiHanmi Pharmaceutical Group was founded in 1973 by Mr. Lim Sung-ki. Its headquarters is located in Seoul, South Korea, and it was listed into South Korea’s stock market in Seoul in 1988. With the business philosophy of people-oriented and value creation, it devotes itself to the research and development of prescription drugs, owning more than 280 patented technologies and becoming a leading player in antibiotics, cardiovascular, digestive, anti-tumor, pediatric and other fields.
It provides more than 200 types of drugs for global clinical treatment and sells patents and transfers technology to international well-known pharmaceutical manufacturers such as Roche and Novartis, so as to become a world-renowned pharmaceutical expert with its world-leading science and technology, advanced equipment and drugs with remarkable curative effect.
It also has subsidiaries such as Hanmi Fine Chemical Co., Ltd., Giheung research institute, Pyeongtaek antibiotics factory and Medi' Care, which lay a solid foundation for its research, development, production and sales. Currently, with a number of subsidiaries in Korea, China, the United States, the United Kingdom, and Japan, Hanmei Group stays committed to becoming an international professional pharmaceutical enterprise with services covering pharmaceuticals, food, maternal and child products, fine chemicals, medical devices, information technology, media, human resources and other fields.
Medi' Care set up three business divisions CBU, HMG and MBU.
2019.10.23 国内首个吸入式氨溴索易安平®️成功上市
2018.10.24 iLELE probiotics was launched to the market
2018.07.01 Hanmi Marketing Group (HMG) joined in Medi' Care.
The international academic exchange group participated in the first exchange activity.
December 2016 Medi' Care became China Association of Non-Public Medical Institutions
Medi' Care became the Vice President Unit of Grassroots Medical Management Sub-Branch
November 18, 2016 Medi' Care Carnival Day was celebrated, with a daily sales of 28,286,237 yuan.
Annual sales exceeded 1 billion for the first time.
The public service propaganda film Mommy Loves Baby won Golden Sunflower Award.
Passed GSP certification.
Net profit broke through 10 million yuan for the first time.
Sales topped 100 million for the first time.
Haishen Ankang was renamed as Beijing Medi' Care Co., Ltd.
